1-(5,6-DIHYDRO-3-(TRIFLUOROMETHYL)-1,2,4-TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)-4-(2,4,5-TRIFLUOROPHENYL)-2-BUTEN-1-ONE, (2Z)-
UNII A86VV335RG
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-(5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo(4,3-a)pyrazin-7(8h)-yl)-4-(2,4,5-trifluorophenyl)-2-buten-1-one, (2z)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A86VV335RG.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1803026-54-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H12F6N4O QSSHJJFVCWMIKH-IWQZZHSRSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-(5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo(4,3-a)pyrazin-7(8h)-yl)-4-(2,4,5-trifluorophenyl)-2-buten-1-one, (2z)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.